Supporting Smoke-Free Policy Compliance in Public Housing (NCT05016505) | Clinical Trial Compass
CompletedNot Applicable
Supporting Smoke-Free Policy Compliance in Public Housing
United States405 participantsStarted 2022-02-03
Plain-language summary
This project seeks to determine the effectiveness of two types of interventions to reduce exposure to secondhand smoke in residential buildings. One intervention is geared toward all building residents (resident endorsement) and the other targets smokers (smoking reduction via relocation and reduction in personal smoking/cessation) with the goal of reducing personal smoking and secondhand smoke exposure.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Building Inclusion Criteria:
* NYCHA buildings in Manhattan \& the Bronx (stratified evenly by borough) with more than 50 units, not undergoing major renovations.
Building Exclusion Criteria:
* Buildings in a borough that is not in Manhattan or the Bronx
* Buildings smaller than 50 units
* Buildings undergoing major renovations
* Buildings that are or will be part of Rental Assistance Demonstration (RAD) or Permanent Affordability Commitment Together (PACT)
* Buildings that are mixed finance
* Buildings that are exclusively for elderly
* Buildings that are privately managed
* Buildings that have other research studies ongoing
Participant Inclusion Criteria:
* Recruit NYCHA residents via door knocking and lobby intercepts until we reach our targeted number per group (4 smokers, 4 non-smokers in each building).
* Residents will be screened for smoking status. Both smokers and non-smokers to be recruited but only one participant- smoker or a non-smoker- will be recruited per apartment.
* Smoking will be defined as those that report using a cigarette or other combustible tobacco product (e.g., little cigar, cigarillo) at least 5 days in the past month. Non-smokers include never smokers and former smokers who had quit 12 months ago or earlier.
* Additional eligibility criteria include individuals above 18 years old living in the building at least 5 days/week and 9 months/year, not planning on moving in the next 2 years.
Participant Exclusion Criteria:
* Individuals with sev…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in number of cigarettes smoked per day
Timeframe: Measured at baseline (in person interview), 3 months (phone interview) and 12 months (in person interview)
2
Change in salivary cotinine
Timeframe: At baseline and at the 12-month follow-up
3
Change in secondhand smoke exposure
Timeframe: Measured at baseline (in person interview), 3 months (phone interview) and 12 months (in person interview)